Overview

Open-Label Study of Thalidomide for Chronic Prostatitis/Chronic Pelvic Pain

Status:
Terminated
Trial end date:
2006-11-01
Target enrollment:
Participant gender:
Summary
To determine the efficacy of thalidomide for treatment of the Chronic Pelvic Pain Syndrome (CPPS).
Phase:
Phase 2
Details
Lead Sponsor:
Kenneth Peters, MD
Collaborators:
Celgene Corporation
William Beaumont Hospitals
Treatments:
Thalidomide